To achieve excellent cancer chemo/gene combination therapy, we developed a pH-sensitive charge-conversion copolymer, P(HPMA-co-MA-hyd-VB6), which bears positive charges at pH 4 and neutral charges at pH 7.4, to facilitate electrostatic interaction with negatively charged FAK siRNA for preparing polyplexes. The gene discussed is PTK2; the disease is cancer.